Fabio Buttari

Plasma β-amyloid in Alzheimer’s disease and vascular disease

IL-1–induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation

Satb1 regulates the effector program of encephalitogenic tissue Th17 cells in chronic inflammation

Adverse Health Effects of Marijuana Use

Changes in Cannabis Potency Over the Last 2 Decades (1995–2014): Analysis of Current Data in the United States

TFOS DEWS II pathophysiology report

Gut microbiome and health: mechanistic insights

Variability in Response to Transcranial Direct Current Stimulation of the Motor Cortex

Immunopathology of multiple sclerosis

EBV and Autoimmunity

Placebo Response Changes Depending on the Neuropathic Pain Syndrome: Results of a Systematic Review and Meta-Analysis

Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial

Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis

Amyloid biomarkers in Alzheimer's disease

Use of DAMPs and SAMPs as Therapeutic Targets or Therapeutics: A Note of Caution

A Systematic Review of Pharmacological Pain Management in Multiple Sclerosis

Cannabinoids and the expanded endocannabinoid system in neurological disorders

The amyloid hypothesis of Alzheimer's disease at 25 years

Hematopoietic mobilization

Multiple Sclerosis

Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome

Pharmacological Actions of Multi-Target-Directed Evodiamine

How neuroinflammation contributes to neurodegeneration

Transcranial direct current stimulation – update 2011

Plasma tau in Alzheimer disease

Cannabinoids for Medical Use

Biomedical Importance of Indoles

Immunology of Acute and Chronic Wound Healing

Cerebrospinal fluid detection of interleukin-1β in phase of remission predicts disease progression in multiple sclerosis

Increased CD8+ T Cell Response to Epstein-Barr Virus Lytic Antigens in the Active Phase of Multiple Sclerosis

Cannabis-based treatment induces polarity-reversing plasticity assessed by theta burst stimulation in humans

Effects of levetiracetam on chronic pain in multiple sclerosis: results of a pilot, randomized, placebo‐controlled study

Transient Receptor Potential Vanilloid 1 Modulates Central Inflammation in Multiple Sclerosis

Cognitive and Cortical Plasticity Deficits Correlate with Altered Amyloid-β CSF Levels in Multiple Sclerosis

Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction

Synaptic Plasticity and PDGF Signaling Defects Underlie Clinical Progression in Multiple Sclerosis

TRPV1 Channels Regulate Cortical Excitability in Humans

Effects of Anodal Transcranial Direct Current Stimulation on Chronic Neuropathic Pain in Patients With Multiple Sclerosis

Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis

A genetic variant of the anti-apoptotic protein Akt predicts natalizumab-induced lymphocytosis and post-natalizumab multiple sclerosis reactivation